RT @synovialjoints: Therapies for AS and nr-AxSpA are coming together. Both AS and nr-AxSpA present with similar burden
Tweet Content
Therapies for AS and nr-AxSpA are coming together. Both AS and nr-AxSpA present with similar burden of disease. TNFi, IL-17i and JAKi now approved for use in nr-AxSpA.
Jose U Scher, SpA Review @RheumNow #ACR22 https://t.co/vcHcd7OyAU
Show on Archive Page
On
Display in Search Results
On
PDQ
Off